# EDGAR Filing Document

**Accession Number:** 0001499655
**File Stem:** 0000940400-26-020345
**Filing Date:** 2026-5
**Character Count:** 6874
**Document Hash:** adad942b7942ad84460256587f4ae233
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000940400-26-020345.hdr.sgml**: 20260521

**ACCESSION NUMBER**: 0000940400-26-020345

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260521

**DATE AS OF CHANGE**: 20260521

**PERIOD START**: 20261231

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Precidian ETFs Trust
- **CENTRAL INDEX KEY:** 0001499655

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 0331

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-22524
- **FILM NUMBER:** 261007528

**BUSINESS ADDRESS:**
- **STREET 1:** PRECIDIAN FUNDS LLC
- **STREET 2:** 350 MAIN STREET, SUITE 9
- **CITY:** BEDMINSTER
- **STATE:** NJ
- **ZIP:** 07921
- **BUSINESS PHONE:** 908-781-0560

**MAIL ADDRESS:**
- **STREET 1:** PRECIDIAN FUNDS LLC
- **STREET 2:** 350 MAIN STREET, SUITE 9
- **CITY:** BEDMINSTER
- **STATE:** NJ
- **ZIP:** 07921

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** NEXT ETFs Trust
- **DATE OF NAME CHANGE:** 20100820

## Series and Classes Contracts Data

### Novo Nordisk A/S (B Shares) ADRhedged (Series ID: S000058687)

| Class ID   | Class Name                            | Ticker Symbol   |
|:---|:---|:---|
| C000192669 | Novo Nordisk A/S (B Shares) ADRhedged | NVOH            |

## Nport-Ex

#### Novo

#### Nordisk

#### A/S

#### (B

#### Shares)

#### ADRhedged™

#### Schedule

#### of

#### Investments
March

31,

2026

(Unaudited)

#### Shares

#### Value

#### Common

#### Stocks

#### —

#### 93.9%

#### Health

#### Care

#### —

#### 93.9%
Novo

Nordisk

A/S

(B

Shares),

ADR

#### (Cost

#### $5,460,493)

#### ........................................................................................................
100,059

$

3,677,168

#### Short-Term

#### Investment

#### —

#### 3.6%

#### Money

#### Market

#### Funds

#### —

#### 3.6%
Dreyfus

Treasury

Securities

Cash

Management

Institutional

Shares,

3.53%

(a) #### (Cost

#### $140,779)

#### ..........................................................................................................
140,779

140,779

#### Total

#### Investments

#### —

#### 97.5%

#### (Cost

#### $5,601,272)
3,817,947

#### Assets

#### in

#### excess

#### of

#### Other

#### Liabilities,

#### Net

#### —

#### 2.5%
97,909

#### Net

#### Assets

#### —

#### 100%
$

3,915,856

_______________

(a) Reflects

the

7-day

yield

at

March

31,

2026. ADR:

American

Depositary

Receipt

At

March

31,

2026,

the

Fund

had

the

following

currency

swaps

outstanding:

#### Counterparty

#### Settlement

#### Date

#### \*

#### Currency

#### to

#### Deliver

#### Currency

#### to

#### Receive

#### Unrealized

#### Appreciation

#### Unrealized

#### Depreciation
CIBC

04/01/26

DKK

22,267,102

USD

3,416,340

$

—

$

(17,080)

CIBC

04/01/26

USD

3,433,369

DKK

22,267,102

—

CIBC

04/02/26

DKK

21,690,298

USD

3,345,245

764

—

CIBC

04/02/26

DKK

1,204,953

USD

185,837

—

#### Total

#### Unrealized

#### Appreciation/(Depreciation)
$

857

$

(17,080)

\*

The

currency

hedge

contracts

have

an

automatic

extension

on

the

maturity

date;

however,

the

currency

hedge

contracts

are

marked

to

market

and

settled

daily

and

the

date

reflected

herein

is

the

next

settlement

date.

Currency

Abbreviations

USD

U.S.

Dollar

DKK

Danish

Krone

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Precidian ETFs Trust

- **b. Investment Company Act file number:** 811-22524

- **c. CIK number of Registrant:** 0001499655

- **d. LEI of Registrant:** 2549009PTGY2C3DLNH87

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 301 S State Street

  - **City:** Newtown

  - **State:** PA

  - **Foreign country:** US

  - **Zip / Postal Code:** 18940

  - **Telephone number:** 908-781-0560

**Item A.2. Information about the Series.**

- **a. Name of Series:** Novo Nordisk A/S (B Shares) ADRhedged

- **b. EDGAR series identifier (if any):** S000058687

- **c. LEI of Series:** 254900HLPLIRDQPWL696

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-12-31

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $3714697.82

**Total Liabilities:** $572.55

**Net Assets:** $3714125.27

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000192669 | 15.09%               | -35.80%              | 3.53%                |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-9476.67                | $539100.89                                 |
| Month 2  | $0.00                    | $-1852056.78                               |
| Month 3  | $0.00                    | $-79730.74                                 |

### Schedule of Portfolio Investments

| Name                               | Title                    | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| DREYFUS TRSRY SECURITIES           | DREYFUS TRSRY SECURITIES | CUSIP: 000000000<br>LEI: N/A                  | Long             | STIV             | RF                | US        |    140779 | NS      | $140778.57    | 3.79%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S                   | Novo Nordisk A/S ADR     | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |     94793 | NS      | $3483642.75   | 93.79%            |  |  |  | No            |                  1 | On Loan: No      |
| CANADIAN IMPERIAL BANK OF COMMERCE | CSWAP DKK VS USD         | CUSIP: 000000000<br>LEI: 2IGI19DL77OX0HC3ZE78 | N/A              | DFE              | CORP              | CA        |         1 | NC      | $-16265.09    | -0.44%            |  |  |  | No            |                  2 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-21

**Name of Applicant:** Precidian ETFs Trust

**Signature:** Daniel McCabe

**Name of Signer:** Daniel McCabe

**Title:** CEO